+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Cachexia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767270
  • Report
  • April 2019
  • Region: Global
  • 122 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Bristol-Myers Squibb Co
  • Endo International Plc
  • Galapagos NV
  • GlaxoSmithKline Plc
  • Helsinn Group
  • IQVIA Holdings Inc
  • MORE
The global clinical trial report- “2019 Cachexia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Cachexia. It presents in-depth analysis of Cachexia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Cachexia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Cachexia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Cachexia

The research work is prepared through extensive and continuous research on Cachexia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Cachexia patients are identified
  • The report includes panorama of Cachexia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Cachexia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bristol-Myers Squibb Co
  • Endo International Plc
  • Galapagos NV
  • GlaxoSmithKline Plc
  • Helsinn Group
  • IQVIA Holdings Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Cachexia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Cachexia Clinical Trials by Region
2.2.2 Average Enrollment of Cachexia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Cachexia Treatment, 2019

3. Region wise Cachexia Clinical Trials
3.1 Asia Pacific Cachexia Clinical Trials by Country
3.2 Europe Cachexia Clinical Trials by Country
3.3 North America Cachexia Clinical Trials by Country
3.4 Middle East and Africa Cachexia Clinical Trials by Country
3.5 South and Central America Cachexia Clinical Trials by Country

4. Cachexia Clinical Trial Trends
4.1 Start Year wise Cachexia Clinical Trials
4.2 Phase wise Cachexia Clinical Trials
4.3 Trial Status wise Cachexia Clinical Trials
4.4 Trial Type wise Cachexia Clinical Trials

5. Cachexia Average Enrollment Trends
5.1 Average Enrollment in Cachexia Trials by Year
5.2 Average Enrollment in Cachexia Trials by Phase
5.3 Average Enrollment in Cachexia Trials by Status
5.4 Average Enrollment in Cachexia Trials by Type of Trial

6. Companies Participating in Cachexia Clinical Trials
6.1 Cachexia Trials by Sponsor Type
6.2 Cachexia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Cachexia Trials- Phase 1
7.2 Cachexia Trials- Phase 2
7.3 Cachexia Trials- Phase 3
7.4 Cachexia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Cachexia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Cachexia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Cachexia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Cachexia Clinical Trials and Enrolment
Figure 7: North America - Country wise Cachexia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Cachexia Clinical Trials and Enrolment
Figure 9: Cachexia Clinical Trials by Phase
Figure 10: Cachexia Clinical Trials by Trial Status
Figure 11: Cachexia Clinical Trials by Type
Figure 12: Cachexia Clinical Trials by Sponsor Type
Figure 13: Cachexia Clinical Trials by Leading Sponsors
Figure 14: Cachexia Average Enrollment by Phase
Figure 15: Cachexia Average Enrollment by Trial Status
Figure 16: Cachexia Average Enrollment by Type
Figure 17: Cachexia- Average Enrolment by Type of Sponsors
Figure 18: Cachexia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Cachexia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Cachexia Clinical Trials and Enrolment
Table 5: Europe - Country wise Cachexia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Cachexia Clinical Trials and Enrolment
Table 7: North America - Country wise Cachexia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Cachexia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Cachexia Average Enrollment by Phase
Table 15: Cachexia Average Enrollment by Trial Status
Table 16: Cachexia Average Enrollment by Type
Table 17: Cachexia- Average Enrolment by Type of Sponsors
Table 18: Cachexia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bristol-Myers Squibb Co
  • Endo International Plc
  • Galapagos NV
  • GlaxoSmithKline Plc
  • Helsinn Group
  • IQVIA Holdings Inc
  • Medpace Holdings Inc
  • Merck KGaA
  • Pamplona Capital Management LLP
  • Pfizer Inc
Note: Product cover images may vary from those shown
Adroll
adroll